Davidson Kempner Capital Management LP

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1595082 New York, NY

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,931,000

+$1,260,000 QoQ

Shares Held

300,000

0.0% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#22

of 97 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davidson Kempner Capital Management LP holds $7,588,160 across 5 Biotechnology names. KPTI ranks #2 (38.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HUMA	Humacyte, Inc.	5,000,000	$3,900,000
2	KPTI	Karyopharm Therapeutics Inc. This page	300,000	$2,931,000
3	AVLN	Avalyn Pharma Inc.	23,000	$757,160
4	MLEC	Moolec Science SA	250,000	$0
5	TVGN	Tevogen Inc.	250,000	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,931,000	300,000	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,671,000	300,000	-3.2%	Shares	Sole	2026-05-15
2025-12-31	$2,281,747	310,020	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.